Cargando…

Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

Natural products were extracted from traditional Chinese herbal emerging as potential therapeutic drugs for treating cardiovascular diseases. This study examines the role and underlying mechanism of dihydromyricetin (DMY), a natural compound extracted from Ampelopsis grossedentata, in atherosclerosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dafeng, Yang, Zhousheng, Chen, Lei, Kuang, Dabin, Zou, Yang, Li, Jie, Deng, Xu, Luo, Songyuan, Luo, Jianfang, He, Jun, Yan, Miao, He, Guixia, Deng, Yang, Li, Rong, Yuan, Qiong, Zhou, Yangzhao, Jiang, Pei, Tan, Shenglan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214150/ https://www.ncbi.nlm.nih.gov/pubmed/32301289 http://dx.doi.org/10.1111/jcmm.15278

Ejemplares similares

Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway
por: Yang, Dafeng, et al.
Publicado: (2018)

Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway
por: Yang, Zhousheng, et al.
Publicado: (2023)

Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis via regulating miR-21 in Human Cholangiocarcinoma Cells
por: Chen, Lei, et al.
Publicado: (2020)

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014)

The Versatile Effects of Dihydromyricetin in Health
por: Li, Hongliang, et al.
Publicado: (2017)

Mechanism of Dihydromyricetin on Inflammatory Diseases
por: Sun, Yang, et al.
Publicado: (2022)

Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
por: Zhang, Jingyao, et al.
Publicado: (2018)

Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
por: Ma, Wenbing, et al.
Publicado: (2022)

Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice
por: Zhou, Yangzhao, et al.
Publicado: (2023)

Research progress of dihydromyricetin in the treatment of diabetes mellitus
por: Wang, Ziyuan, et al.
Publicado: (2023)

SOCS3 Gene Polymorphism and Hypertension Susceptibility in Chinese Population: A Two-Center Case-Control Study
por: Kuang, Dabin, et al.
Publicado: (2021)

Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis
por: Li, Yang, et al.
Publicado: (2023)

Association of lncRNA PVT1 Gene Polymorphisms with the Risk of Essential Hypertension in Chinese Population
por: Li, Rong, et al.
Publicado: (2022)

Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)

Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma
por: Li, Xin, et al.
Publicado: (2021)

Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
por: LIU, JIE, et al.
Publicado: (2014)

Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
por: Cheng, Quan-Cheng, et al.
Publicado: (2020)

Dihydromyricetin promotes longevity and activates the transcription factors FOXO and AOP in Drosophila
por: Fan, Xiaolan, et al.
Publicado: (2020)

New Method for Extracting and Purifying Dihydromyricetin from Ampelopsis grossedentata
por: Hu, Hongchao, et al.
Publicado: (2020)

The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21
por: Xu, Xiaona, et al.
Publicado: (2019)

Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice
por: Xu, Jiqu, et al.
Publicado: (2018)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
por: Fang, Bin, et al.
Publicado: (2018)

Application of rapid artificial cardiac pacing in thoracic endovascular aortic repair in aged patients
por: Chen, Jun, et al.
Publicado: (2013)

Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice
por: Cheng, Long, et al.
Publicado: (2021)

An Approach to Speed up Single-Frequency PPP Convergence with Quad-Constellation GNSS and GIM
por: Cai, Changsheng, et al.
Publicado: (2017)

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
por: Wu, Bin, et al.
Publicado: (2017)

Mechanism and antibacterial activity of vine tea extract and dihydromyricetin against Staphylococcus aureus
por: Liang, Haiyun, et al.
Publicado: (2020)

Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Du, Meng, et al.
Publicado: (2019)

Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice
por: Singh, Nikhlesh K., et al.
Publicado: (2015)

Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice
por: Zhou, Lichun, et al.
Publicado: (2013)

Gastric floating sustained-release tablet for dihydromyricetin: Development, characterization, and pharmacokinetics study
por: Liu, Hao, et al.
Publicado: (2019)

MiR-520a-3p Inhibited Macrophage Polarization and Promoted the Development of Atherosclerosis via Targeting UVRAG in Apolipoprotein E Knockout Mice
por: Qi, Jing Rui, et al.
Publicado: (2021)

Whole Body Vibration Retards Progression of Atherosclerosis via Insulin-Like Growth Factor 1 in Apolipoprotein E-Deficient Mice
por: Wu, He, et al.
Publicado: (2018)

Continuous Hypobaric Hypoxia may Promote Atherosclerosis Progression in Apolipoprotein E-deficient Mice
por: Luo, Shouming, et al.
Publicado: (2023)

Effects of Chronic Mild Stress on the Development of Atherosclerosis and Expression of Toll-Like Receptor 4 Signaling Pathway in Adolescent Apolipoprotein E Knockout Mice
por: Gu, Hongfeng, et al.
Publicado: (2009)

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis
por: Xiao, Ting, et al.
Publicado: (2021)

Association with inflammatory cells and apolipoproteins to the progression of atherosclerosis
por: Eo, Hyun-Seon, et al.
Publicado: (2011)

Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
por: Wu, Jiajun, et al.
Publicado: (2022)

Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation
por: Zhang, Shuo, et al.
Publicado: (2023)

Activation of CREB Protein With Tabersonine Attenuates STAT3 During Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Shi, Sen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n3nm4asp2bhtpgrdhme0bce3kt